星星科技(300256.SZ)擬對下屬子公司增資
格隆匯7月29日丨星星科技(300256.SZ)公佈,為拓寬融資渠道,提升公司綜合競爭力,公司控股子公司江西星星科技有限責任公司(以下簡稱“江西星星”)擬通過自籌資金向其全資子公司奇卉諮詢(深圳)有限公司(以下簡稱“奇卉諮詢”)以現金方式增資人民幣8900萬元,增資完成後,奇卉諮詢註冊資本由100萬元增加至9000萬元,仍為江西星星全資子公司;奇卉諮詢擬通過自籌資金向其全資子公司前海宇通商業保理(深圳)有限公司(以下簡稱“宇通保理”)以現金方式增資人民幣2.7億元,增資完成後,宇通保理註冊資本由3000萬元增加至3億元,仍為奇卉諮詢全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.